23 Aug 2019 11:21
Â
 |  |
 |  |
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i | |
 | |
Â
Â
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii | e-Therapeutics PLC |
Â
Â
2 Reason for the notification (please tick the appropriate box or boxes): | ||
An acquisition or disposal of voting rights | âś“ | |
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | Â | |
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | Â | |
An event changing the breakdown of voting rights | Â | |
Other (please specify): |
| Â |
| Â | Â | Â |
Â
Â
3. Full name of person(s) subject to the notification obligation: iii | Rupert Labrum |
4. Full name of shareholder(s) (if different from 3.): iv | Â |
5. Date of the transaction and date on which the threshold is crossed or reached: v | 22/08/2019 |
6. Date on which issuer notified: | 23/08/2019 |
7. Threshold(s) that is/are crossed or reached: vi, vii | 5.00% |
Â
Â
8. Notified details: | |||||||
A: Voting rights attached to shares viii, ix | |||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | |||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights x | |||
Direct | Direct xi | Indirect xii | Direct | Indirect | |||
GB00B2823H99 | 12015000 | 12015000 | 13449017 | 13449017 | Â | 5.0% | Â |
Â
Â
B: Qualifying Financial Instruments | ||||
Resulting situation after the triggering transaction | ||||
Type of financialinstrument | Expirationdate xiii | Exercise/ Conversion Period xiv | Number of votingrights that may beacquired if theinstrument isexercised/ converted. | % of votingrights |
 |  |  |  |  |
Â
Â
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi | ||||||
Resulting situation after the triggering transaction | ||||||
Type of financialinstrument | Exercise price | Expiration date xvii | Exercise/Conversion period xviii | Number of voting rights instrument refers to | % of voting rights xix, xx | |
 |  |  |  |  | Nominal | Delta |
 |  | |||||
Â
Â
Total (A+B+C) | |
Number of voting rights | Percentage of voting rights |
13449017 | 5.0% |
Â
Â
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi |
 |
Â
Â
Proxy Voting: | |
10. Name of the proxy holder: | Â |
11. Number of voting rights proxy holder will cease to hold: | Â |
12. Date on which proxy holder will cease to hold voting rights: | Â |
Â
Â
13. Additional information: | Â |
14. Contact name: | Â Rupert Labrum |
15. Contact telephone number: | Â |
Â
Â
Â
Follow the stocks